
Single dose of bisphosphonate preserves gains in bone mass following cessation of sclerostin antibody in Brtl/+ osteogenesis imperfecta model
Keywords: بیسفسفونات; Osteogenesis imperfecta; Sclerostin antibody; Cessation; Bisphosphonate; Osteoporosis;